We bring the best of a cutting-edge research lab coupled with the flexibility and reliability of a company.
Our specific tools are ideal for work in various areas:
- Alzheimer’s (neuroinflammation, white matter hyperintensity, fiber tractography and bundling
- Parkinson’s (neuroinflammation, fiber tractography and bundling)
- Multiple sclerosis (lesion segmentation, fiber tractography and bundling)
Our ongoing projects also include other orphan neurodegenerative diseases, mood disorders and schizophrenia.
With a limited number of directions of acquisition, we can extract significant information from data acquired in the past. Past projects have been completed with ADNI database, from which we have extracted information; something that had never been done before.
If you are conducting or planning a clinical trial, and the image acquisition protocols are based on ADNI or PPMI and already set, or if you are using another public database, Imeka can work with the data.
Our acquisition sequences for high-quality diffusion MRI processing is quite short, as little as 5 minutes, never exceeding 10 minutes.
Adding quality image acquisitions for neuroinflammation, fiber tractography and fiber bundling can be done at almost no extra acquisition cost.
In order to streamline our service to you, we have optimized our image acquisition sequences and image processing to be able to accommodate Siemens, GE, Philips MRIs, 1.5T and 3T.
In other words, any pilot study is scalable to any MRI in the world, simplifying your next phase III study.